Menu
Recruiting NCT06603194

Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy Adults

No phase Interventional Skin Laxity Hair Thinning Nails

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Bovine or Marine Collagen.
Who it may be relevant to
Registry conditions: Skin Laxity, Hair Thinning, Nails. Basic parameters: 35 years — 55 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

BECOME Study: Comparative Efficacy of Bovine and Marine Collagen Versus Placebo on Skin, Hair, Nails and Whole Body Health Markers

Overview

The BECOME Study (Bovine and Marine Collagen Efficacy for Skin, Hair, Nails and Whole Body Health Markers Evaluation) is a randomized controlled trial designed to compare the effects of bovine and marine collagen supplements versus a placebo on skin, hair, nails and whole body health markers. The trial aims to determine the most efficacious collagen source for improving health outcomes and to establish if both types of collagen are equally effective. Participants will be assessed on various health parameters, including skin elasticity, joint health, digestive health, and overall well-being, over a specified period.

Interventions

  • Dietary supplement Bovine or Marine Collagen
    Bovine or Marine Collagen

Primary outcome measures

  • Change in nail strength and growth [Time frame: Baseline, week 6 and week 12]
  • Change in skin elasticity [Time frame: Baseline, week 6 and week 12]
  • Change in hair thickness and strength [Time frame: Baseline, week 6 and week 12]
  • Change in skin wrinkles [Time frame: Baseline, week 6 and week 12]
  • Change in perceived skin health [Time frame: Baseline, week 6 and week 12]
  • Change in skin wrinkles by visual assessment [Time frame: Baseline, week 6 and week 12]
  • Changes in skin pigmentation [Time frame: Baseline, week 6 and week 12]
  • Changes in skin hydration [Time frame: Baseline, week 6 and week 12]
Secondary outcome measures (2)
  • Digestive Quality of Life (DQDL) Assessment [Time frame: Baseline, week 6 and week 12]
  • Subjective Perception Questionnaire [Time frame: Baseline, week 6 and week 12]

Eligibility criteria

Inclusion criteria

Females aged 35-55 years. Participants must be comfortable with bovine or marine collagen (non-vegan/vegetarian).

Must provide informed consent and be willing to comply with study requirements.

Exclusion criteria

Pregnant or breastfeeding women. History of chronic skin conditions (e.g., eczema, psoriasis) that might interfere with study outcomes.

Any active skin infections or severe acne. Currently taking collagen supplements or have taken them within the last 6 months.

Use of medications or topical agents that can affect skin, hair, nails, or gastrointestinal health (e.g., corticosteroids, retinoids).

Excessive alcohol consumption or current smokers. Regular use of sunbeds. Recent cosmetic procedures (e.g., Botox, fillers, chemical peels, laser treatments) on skin, hair, or nails within the last 3 months.

Any condition or situation that, in the opinion of the investigator, may interfere with the participant's ability to comply with the study requirements or give informed consent.

Poor adherence to previous study protocols

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Prevention

Study locations

United Kingdom · 1 center
  • Princeton Consumer Research, 8 Richmond Road, Dukes Park — Chelmsford

Identifiers

NCT: NCT06603194 · AABVIV1C

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗